MRNA Latest Headlines

SPDR S&P 500 ETF Trust (SPY) Daily Update, 2/24/2026

at www.tipranks.com (Tue, 24-Feb 5:04 PM)

Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?

at www.tipranks.com (Tue, 24-Feb 2:19 PM)

CDC vaccine panel to meet in March after delay

at seekingalpha.com (Tue, 24-Feb 12:06 PM)

Why Is Vanguard S&P 500 ETF (VOO) Up Today, 2/24/2026?

at www.tipranks.com (Tue, 24-Feb 8:50 AM)

SPDR S&P 500 ETF Trust (SPY) Daily Update, 2/23/2026

at www.tipranks.com (Mon, 23-Feb 5:00 PM)

“J&J’s Claims of Superiority… Are False”: Johnson & Johnson Stock Rises despite Bayer Lawsuit

at www.tipranks.com (Mon, 23-Feb 11:36 AM)

Why Is Vanguard S&P 500 ETF (VOO) Down Today, 2/23/2026?

at www.tipranks.com (Mon, 23-Feb 7:38 AM)

Why Is Vanguard S&P 500 ETF ($VOO) Down Today, 2/23/2026?

at www.tipranks.com (Mon, 23-Feb 7:38 AM)

Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

at www.benzinga.com (Sun, 22-Feb 9:05 AM)

Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus

at seekingalpha.com (Sun, 22-Feb 9:05 AM)

Moderna Faces Default Risk as Ares Capital–Led Lenders Gain Power to Accelerate Debt and Seize Collateral

at www.tipranks.com (Sun, 22-Feb 1:01 AM)

Moderna Stock Soars as Flu Reversal Ignites Hopes

at www.tipranks.com (Sat, 21-Feb 9:01 AM)

Moderna’s Flu Vaccine Heads for FDA Review: Key Milestone Set for 2026 Availability

Market Chameleon (Wed, 18-Feb 7:37 AM)

Moderna Targets Revenue Growth and Cost Discipline as Pipeline Advances in 2026

Market Chameleon (Fri, 13-Feb 7:10 AM)

MRNA's Five-Year Data Shows 49% Recurrence-Free Survival Edge—Is Precision Oncology Entering a New Era?

Market Chameleon (Thu, 5-Feb 9:35 AM)

Leadership Overhaul at Moderna: Appointment of Dr. David Berman Signals Focus on Oncology Innovation

Market Chameleon (Fri, 30-Jan 7:39 AM)

Moderna Schedules Q4 2025 Earnings Call for February 13, 2026—Investors Eye Updates on mRNA Pipeline

Market Chameleon (Mon, 26-Jan 8:40 AM)

How this MRNA Bull Put Spread Could Make 20% in 6 Days

Market Chameleon (Thu, 22-Jan 12:51 PM)

MRNA Iron Condor Spread Can Make 71% in Next 6 Days

Market Chameleon (Thu, 22-Jan 11:32 AM)

MRNA & Merck Reveal 49% Reduction in Cancer Recurrence Risk—Five-Year Melanoma Data Reinforce Long-Term Potential

Market Chameleon (Tue, 20-Jan 7:13 AM)

Moderna Seeks Global Approvals for mRNA Flu Vaccine as Phase 3 Data Show Consistent Efficacy in Older Adults

Market Chameleon (Mon, 5-Jan 9:07 AM)